Excalibur Management Corp
Source: SEC Form 13F · as of Mar 2026Excalibur Management Corp holds 14 biotech & pharma companies tracked by BioSniper, totaling $36.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$36.1M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 37,425 | $9.1M |
| MRKMerck & Co., Inc. | 51,737 | $6.2M |
| PFEPFIZER INC | 151,843 | $4.3M |
| GILDGILEAD SCIENCES, INC. | 21,447 | $3.0M |
| ABBVAbbVie Inc. | 13,479 | $2.9M |
| AMGNAMGEN INC | 6,411 | $2.3M |
| BMYBRISTOL MYERS SQUIBB CO | 32,865 | $2.0M |
| PMPhilip Morris International Inc | 9,118 | $1.5M |
| ABTABBOTT LABORATORIES | 13,628 | $1.4M |
| LLYELI LILLY & Co | 1,408 | $1.3M |
| MCKMcKesson Corporation | 1,213 | $1.0M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 11,688 | $645K |
| NVSNovartis AG | 1,828 | $279K |
| OGNOrganon & Co. | 11,629 | $70K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.